Pages
Setting up a bank in Britain gets easier
Stephen Beard Apr 29, 2013
Despite the recent global banking crisis, UK regulators have decided to cut down application approval times for new banks and lower the capital requirements. An American starting a bank there says this will stimulate competition.
California bets big on marketing to spread the health care gospel
Aarti Shahani Apr 25, 2013
Millions of Californians will be eligible for healthcare under the new law, and lots of them know nothing about it.
Britain celebrates its Huguenot heritage
Stephen Beard Apr 24, 2013
Immigration is a contentious issue in Britain, but the country recently celebrated one of the most successful immigrant groups -- French Protestants or Huguenots.
Genetics may be the next big thing in medicine, but at what cost?
Dan Gorenstein Apr 12, 2013
Many believe genetics are the next big thing in medicine, but one question for this new era of personalized medicine is cost.
'Chained CPI' hurts seniors
Robert Reich Apr 10, 2013
Obama's proposal to recalculate the rate of inflation hurts seniors who spend more on health care than the rest of us.
Margaret Thatcher's foes turned anger into big business, and a soundtrack for the '80s
Stacey Vanek Smith Apr 8, 2013
From punk rock to TV satires such as Spitting Image, many of those who set out to pillory Margaret Thatcher for her policies made a nice living doing so. Listen to the soundtrack that hate created.
Dementia is highest cost disease and rising
Dan Gorenstein Apr 4, 2013
A report in the latest issue of the New England Journal of Medicine says the U.S. spends more on treating dementia than any other disease including cancer and heart disease.
Nursing exams keep pace with health care tech advances
Kate Casey Apr 2, 2013
It helps to be up on the latest tech if you want to be a registered nurse. This week the National Council of State Boards of Nursing is rolling out a new update to its nurse licensing exam.
India Novartis patent ruling: Good for access, bad for innovation?
Dan Gorenstein Apr 1, 2013
India's Supreme Court has rejected a patent filed by Swiss drug maker Novartis for its cancer drug. The decision has implications for the pharmaceutical industry and millions of people in poor countries.
India rejects Novartis cancer drug patent
Rahul Tandon Apr 1, 2013
The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment.
